Vpr驱动的TRAIL-R2表达缺失保护HIV感染细胞免受非经典NK细胞TRAIL攻击

Loss of Vpr-driven TRAIL-R2 expression protects HIV-infected cells from non-canonical NK cell TRAIL attack.

作者信息Paula E Grasberger, Abigail R Sondrini, Nicole Glidden, Amanda Modica, Natalie Pushlar, Seden Bedir, Tara Bromfield, Sheldon Gentling, Komal Cheema, Alper Kucukural, Milena Ozdemir, Maria Zapp, Alberto Bosque, Louise Leyre, Aaron Shulkin, Alicja Piechocka-Trocha, R Brad Jones, Kiera L Clayton
PMID42039429
期刊bioRxiv
发布时间2026-04-19
DOI10.64898/2026.04.15.718741

实验完整度

中

文献基于实验结果提出Vpr诱导TRAIL-R2表达并增强NK杀伤的机制,包含细胞共培养和功能验证。

主要模型

原代CD4+ T细胞 NK细胞 HIV感染细胞

重点核对

HIV感染者来源的CD4+ T细胞中Vpr表达与TRAIL-R2表达的相关性 NK细胞与HIV感染细胞共培养后杀伤效率的检测 TRAIL-R2表达水平对NK细胞杀伤效率的影响

摘要

HIV escapes sterilizing immunity through a variety of mechanisms, including the downregulation of MHC-I expression by HIV Nef and Vpu to counteract CD8 + T cell responses. While reduced MHC-I expression would be expected to support targeting by NK cells, a subpopulation of infected CD4 + T cells consistently resists multiple rounds of NK cell natural and antibody-dependent cytotoxicity. Studies further reveal that the HIV accessory protein Vpr induces expression of TNFRSF10B (TRAIL-R2) in CD4 + T cells, with 'survivors' of NK cell targeting exhibiting relatively higher MHC-I and weaker expression of TRAIL-R2. In fact, reverse TRAIL signaling in NK cells leads to the release of perforin and granzymes, a pathway limited when TRAIL-R2 expression is diminished. Thus, independent of canonical death receptor signaling, TRAIL-R2 serves as an activating ligand that augments NK cell killing. These observations demonstrate that through Vpr, HIV can regulate the TRAIL/TRAIL-R2 axis to control NK cell functionality.

实验结论

提炼研究问题、关键发现与证据,快速把握文章的核心贡献。

研究问题
HIV感染细胞如何逃避NK细胞杀伤?
核心机制
HIV Vpr蛋白诱导感染细胞表达TRAIL-R2,作为激活配体增强NK细胞通过反向TRAIL信号释放穿孔素和颗粒酶杀伤细胞。
主要证据
体外实验显示Vpr上调TRAIL-R2,且TRAIL-R2表达增强NK细胞杀伤;NK杀伤后存活细胞表现为TRAIL-R2低表达。
研究意义
揭示HIV通过Vpr调控TRAIL/TRAIL-R2轴以控制NK细胞功能的机制,为感染控制和免疫治疗提供新靶点。